Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board.

MLA

Kao, Steven C., et al. “Validation of Prognostic Factors in Malignant Pleural Mesothelioma: A Retrospective Analysis of Data from Patients Seeking Compensation from the New South Wales Dust Diseases Board.” Clinical Lung Cancer, vol. 14, no. 1, Jan. 2013, pp. 70–77. EBSCOhost, https://doi.org/10.1016/j.cllc.2012.03.011.

APA

Kao, S. C., Vardy, J., Chatfield, M., Corte, P., Pavlakis, N., Clarke, C., van Zandwijk, N., & Clarke, S. (2013). Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board. Clinical Lung Cancer, 14(1), 70–77. https://doi.org/10.1016/j.cllc.2012.03.011

Chicago

Kao, Steven C, Janette Vardy, Mark Chatfield, Peter Corte, Nick Pavlakis, Christopher Clarke, Nico van Zandwijk, and Stephen Clarke. 2013. “Validation of Prognostic Factors in Malignant Pleural Mesothelioma: A Retrospective Analysis of Data from Patients Seeking Compensation from the New South Wales Dust Diseases Board.” Clinical Lung Cancer 14 (1): 70–77. doi:10.1016/j.cllc.2012.03.011.